Liver cancerA study looking at how people manage symptoms that could be cancer (CLOCS-2)
This study is looking at the products people buy to help with vague symptoms that could be cancer.
Liver cancer
Available
Available
A study looking at new ways to spot liver cancer early (PEARL)
This study is looking at blood and urine samples to try to pick up liver cancer earlier.
A trial of aspirin to reduce the risk of cancer in people with primary sclerosing cholangitis (Asp-PSC)
This trial is looking at aspirin to try and reduce the risk of cancer for people with primary sclerosing cholangitis and inflammatory bowel disease.
A study looking at using biomarkers and MRI scans to spot liver cancer early (SELiNa)
This study is looking at blood samples and MRI scans to pick up liver cancer earlier.
A study looking at changes to the liver and the immune system to improve the diagnosis of cancer (DELPHI)
This study is looking at changes to the liver and the immune system which could help diagnose liver cancer at an early stage.
A trial of TACE, pembrolizumab and lenvatinib for cancer of the liver (LEAP-012)
This trial is looking at adding pembrolizumab and lenvatinib to TACE to improve treatment for liver cancer.
A trial looking at volrustomig, bevacizumab and lenvatinib for liver cancer that has spread (GEMINI-Hepatobiliary - Sub study one)
This trial is looking at having a new drug called volrustomig (MEDI5752) on its own for liver cancer.
A trial of AZD5069 and durvalumab for cancer that started in the liver (CUBIC)
This trial is looking at AZD5069 and durvalumab for the most common type of liver cancer called hepatocellular carcinoma (HCC).
A trial of pembrolizumab and lenvatinib for liver cancer (PRIMER-1)
This trial is looking at giving pembrolizumab and lenvatinib before surgery for people with liver cancer.
A study of MIV-818 for liver cancer
This study is looking at MIV-818 in combination with lenvatinib or pembrolizumab for people with advanced liver cancer.